SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-050645
Filing Date
2022-09-19
Accepted
2022-09-19 19:24:31
Documents
2
Period of Report
2022-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11699
2 POA DOCUMENT poa.txt EX-24 3692
  Complete submission text file 0001209191-22-050645.txt   16864
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO THERAPEUTICS, INC. 7000 MARINA BOULEVARD BRISBANE CA 94005
Business Address
Dubois-Stringfellow Nathalie (Reporting) CIK: 0001947007 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30171 | Film No.: 221251785